Clinical Trials Browser

OTHER × Uterine Cervical Dysplasia × Papillomavirus Vaccines × Clear all

Acquired Immunodeficiency Syndrome, Uterine Cervical Dysplasia, Papillomavirus Infections

NCT06862102 2025-03-10

HPV dysplasia

Recruiting

152 enrolled

Gynecologic

Uterine Cervical Dysplasia

NCT06700941 2024-11-22

Impact of HPV Vaccination Against Cervical Lesions and Genital Warts in Colombia. an Ecological Assessment

Completed

8,000,000 enrolled

Gynecologic

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Condylomata Acuminata, Papillomavirus Infections

NCT01928225 2020-06-24

Randomized, Double Blind Trial of the Quadrivalent HPV Vaccine to Improve Responses to LEEP Treatment of Cervical HSIL

Phase 2 Completed

180 enrolled 11 charts

Gynecologic

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

NCT01735006 2020-02-24

Efficacy and Immunogenicity Study of Recombinant Human Papillomavirus Bivalent（Type 16/18 ）Vaccine

Phase 3 Completed

7,372 enrolled

Gynecologic

Persistent Infection, Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

NCT04171505 2019-11-21

VENUS

Unknown

508 enrolled

Gynecologic

Uterine Cervical Dysplasia, Papillomavirus Infections

NCT01356823 2016-01-05

Dose-Ranging Study of Recombinant Human Papillomavirus Virus 16/18 Bivalent Vaccine

Phase 2 Completed

1,600 enrolled

Gynecologic

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

NCT01034358 2012-10-23

Immune Response to the Human Papillomavirus Vaccine in Young Women With Inflammatory Bowel Disease

Phase 4 Completed

15 enrolled 6 charts

Gynecologic

Uterine Cervical Dysplasia, Colitis, Ulcerative, Crohn Disease, Inflammatory Bowel Diseases

Clinical Trials

AGO-Gard

HPV dysplasia

Impact of HPV Vaccination Against Cervical Lesions and Genital Warts in Colombia. an Ecological Assessment

Randomized, Double Blind Trial of the Quadrivalent HPV Vaccine to Improve Responses to LEEP Treatment of Cervical HSIL

Efficacy and Immunogenicity Study of Recombinant Human Papillomavirus Bivalent（Type 16/18 ）Vaccine

VENUS

Dose-Ranging Study of Recombinant Human Papillomavirus Virus 16/18 Bivalent Vaccine

Immune Response to the Human Papillomavirus Vaccine in Young Women With Inflammatory Bowel Disease